Novartis Ag (NVS) Shares Outstanding (Weighted Average) (2017 - 2025)
Novartis Ag (NVS) has disclosed Shares Outstanding (Weighted Average) for 9 consecutive years, with $766.0 million as the latest value for Q4 2025.
- Quarterly Shares Outstanding (Weighted Average) fell 3.4% to $766.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $766.0 million through Dec 2025, down 3.4% year-over-year, with the annual reading at $766.0 million for FY2025, 3.4% down from the prior year.
- Shares Outstanding (Weighted Average) hit $766.0 million in Q4 2025 for Novartis Ag, down from $793.0 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $2.1 billion in Q4 2022 to a low of $766.0 million in Q4 2025.
- Historically, Shares Outstanding (Weighted Average) has averaged $1.1 billion across 5 years, with a median of $825.0 million in 2023.
- Biggest five-year swings in Shares Outstanding (Weighted Average): soared 135.25% in 2022 and later plummeted 61.08% in 2023.
- Year by year, Shares Outstanding (Weighted Average) stood at $901.0 million in 2021, then surged by 135.25% to $2.1 billion in 2022, then plummeted by 61.08% to $825.0 million in 2023, then decreased by 3.88% to $793.0 million in 2024, then fell by 3.4% to $766.0 million in 2025.
- Business Quant data shows Shares Outstanding (Weighted Average) for NVS at $766.0 million in Q4 2025, $793.0 million in Q4 2024, and $825.0 million in Q4 2023.